Lactation drug cabergoline may reduce breast cancer risk in mothers
An international team of scientists has found that a lactation drug could reduce the risk of breast cancer in mothers after childbirth.
Read original article on The Medical News →Related news
-
Popular sports supplement may help shield the brain from damage linked to gut inflammation
United Kingdom
-
Study: Food prescription programs for food-insecure older adults work best when fresh food is delivered to their door
United Kingdom
-
New paper urges adoption of green AI in healthcare
United Kingdom
-
Researchers identify key pathway that drives T-cell exhaustion in cancer immunotherapy
United Kingdom
-
CHEST announces first pulmonary certification program for nurse practitioners and physician assistants
United Kingdom
-
New trial aims to test whether a blood test can detect breast cancer earlier than mammograms
United Kingdom
-
Highly sensitive people react to social cues over physical environments
United Kingdom
-
Learn CPR: Why it matters more than you may realize
United Kingdom